Yahoo Finance - GhSink

Yahoo Finance

Rumble shares slide on fourth quarter earnings miss

Rumble shares slide on fourth quarter earnings mis...

3 weeks ago 15

Alibaba Could Be the Sleeper AI Winner in 2026

Alibaba Could Be the Sleeper AI Winner in 2026

3 weeks ago 9

Do Private Jobs Data Complement or Contradict Official Statistics?

Do Private Jobs Data Complement or Contradict Offi...

3 weeks ago 8

Cinnaholic redeploys Square systems across franchise network

Cinnaholic redeploys Square systems across franchi...

3 weeks ago 19

Warren Buffett Recommends This 1 Investment to All Investors. Here's How It Could Help Build a Million-Dollar Portfolio.

Warren Buffett Recommends This 1 Investment to All...

3 weeks ago 20

Six Flags Sells Some Parks to EPR: Who Wins?

Six Flags Sells Some Parks to EPR: Who Wins?

3 weeks ago 18

Equinor and Wellesley launch joint NCS exploration project

Equinor and Wellesley launch joint NCS exploration...

3 weeks ago 21

A shocking percentage of people earning more than $300,000 live paycheck to paycheck. Why these wealthy people burn through cash.

A shocking percentage of people earning more than ...

3 weeks ago 20

Sphere Entertainment Co. (SPHR) Rallies on Strong Demand for The Wizard of Oz at Las Vegas Sphere

Sphere Entertainment Co. (SPHR) Rallies on Strong ...

3 weeks ago 24

IDEAYA Biosciences, Inc. (IDYA) Enrolls First Patient in Phase 1 Trial of IDE034 Bispecific ADC

IDEAYA Biosciences, Inc. (IDYA) Enrolls First Pati...

3 weeks ago 17

Stifel Lowers Its Price Target on Eos Energy Enterprises, Inc. (EOSE) to Maintains a Buy Rating

Stifel Lowers Its Price Target on Eos Energy Enter...

3 weeks ago 15

H.C. Wainwright Raises its Price Target on CG Oncology, Inc. (CGON) to $80 and Maintains a Buy Rating

H.C. Wainwright Raises its Price Target on CG Onco...

3 weeks ago 13

Oppenheimer Raises Its Price Target on Tarsus Pharmaceuticals, Inc. (TARS) to $105 and Maintains an Outperform Rating

Oppenheimer Raises Its Price Target on Tarsus Phar...

3 weeks ago 16

Truist Raises Its Price Target on BridgeBio Pharma, Inc. (BBIO) to $95 and Maintains a Buy Rating

Truist Raises Its Price Target on BridgeBio Pharma...

3 weeks ago 13

H.C. Wainwright Lowered Its Price Target on SoundHound AI, Inc. (SOUN) to $20 and Maintains a Buy Rating

H.C. Wainwright Lowered Its Price Target on SoundH...

3 weeks ago 15

Truist Raises Its Price Target on CoreWeave, Inc. (CRWV) to $85 and Maintains a Hold Rating

Truist Raises Its Price Target on CoreWeave, Inc. ...

3 weeks ago 13

Guggenheim Raises Its Price Target on Arcutis Biotherapeutics, Inc. (ARQT) to $35 and Maintains a Buy Rating

Guggenheim Raises Its Price Target on Arcutis Biot...

3 weeks ago 13

RBC Capital Lowers Its Price Target on Viridian Therapeutics, Inc. (VRDN) to $42 and Maintains an Outperform Rating

RBC Capital Lowers Its Price Target on Viridian Th...

3 weeks ago 14